Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Retatrutide is an investigational peptide-based medication designed to act on multiple hormone receptors involved in appetite control, glucose regulation, and energy expenditure
Appetite tends to rise when GLP-1 activity goes down
Retatrutide (a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors) is a 39-amino-acid synthetic peptide currently in Phase 3 clinical research under the development designation LY3437943
Emerging views of mitophagy in immunity and autoimmune diseases
Welcome to the most common mistake men make on TRT: crushing their estrogen in a misguided attempt to optimize their
US$ 28.41
US$ 20.79
/media/img/mt/2026/07/PeptideGoldRush/original.png){kind=icon}
US$ 28.05
US$ 23.46
US$ 27.98
US$ 20.51
US$ 29.64
US$ 25.10
